已发表论文

胰腺类肝细胞癌手术切除联合动脉化疗栓塞和免疫治疗:一病例报告

 

Authors He J, Zhao Q, Liu Q, Li F, He L, Liu M, Yan X

Received 8 June 2021

Accepted for publication 24 July 2021

Published 26 August 2021 Volume 2021:14 Pages 4575—4578

DOI https://doi.org/10.2147/OTT.S323811

Checked for plagiarism Yes

Review by Single anonymous peer review

Peer reviewer comments 2

Editor who approved publication: Dr Arseniy Yuzhalin


Abstract: Pancreatic hepatoid carcinoma (HC) is a heterogeneous tumor with high degree of malignancy and poor prognosis, which display cytological and/or structural features of focal hepatocellular carcinoma (HCC). For the low incidence and atypical clinical symptoms, it is possible to be diagnosed as pancreatic cancer before operation, and mainly depending on the pathological examination. To the best of our knowledge, surgery combined with radiotherapy and chemotherapy is the common treatment of pancreatic HC. However, the curative effect and prognosis is poor. We report a case of 44-year-old woman with pancreatic HC treated with PD-1 receptor inhibitor and transarterial chemoembolization, whose clinical symptoms and laboratory indexes are significantly improved after treatment.
Keywords: pancreatic hepatoid carcinoma, surgical resection, transarterial chemoembolization, immunotherapy, case report